Multiple antimicrobial resistant Salmonella enterica serovar Paratyphi B variant Java in cattle: a case report

2005 ◽  
Vol 156 (11) ◽  
pp. 343-346 ◽  
Author(s):  
S. J. Evans ◽  
R. H. Davies ◽  
S. H. Binns ◽  
E. Liebana ◽  
T. W. H. Jones ◽  
...  
2012 ◽  
Vol 02 (04) ◽  
pp. 63-64
Author(s):  
Ganesh H. R. ◽  
Vimal Kumar Karnaker ◽  
Sanjeev H. ◽  
Rekha Rai ◽  
Asha Pai K. B. ◽  
...  

AbstractA female infant admitted with pyogenic meningitis due to Salmonella enterica serotype Paratyphi B. The organism was isolated from CSF and blood cultures.


2020 ◽  
Vol 103 (1) ◽  
pp. 231-233
Author(s):  
Farhana Khanam ◽  
Nazmul Hasan Rajib ◽  
Susan Tonks ◽  
Md. Khalequzzaman ◽  
Andrew J. Pollard ◽  
...  

2010 ◽  
Vol 192 (24) ◽  
pp. 6465-6476 ◽  
Author(s):  
Vartul Sangal ◽  
Heather Harbottle ◽  
Camila J. Mazzoni ◽  
Reiner Helmuth ◽  
Beatriz Guerra ◽  
...  

ABSTRACT Salmonellosis caused by Salmonella enterica serovar Newport is a major global public health concern, particularly because S. Newport isolates that are resistant to multiple drugs (MDR), including third-generation cephalosporins (MDR-AmpC phenotype), have been commonly isolated from food animals. We analyzed 384 S. Newport isolates from various sources by a multilocus sequence typing (MLST) scheme to study the evolution and population structure of the serovar. These were compared to the population structure of S. enterica serovars Enteritidis, Kentucky, Paratyphi B, and Typhimurium. Our S. Newport collection fell into three lineages, Newport-I, Newport-II, and Newport-III, each of which contained multiple sequence types (STs). Newport-I has only a few STs, unlike Newport-II or Newport-III, and has possibly emerged recently. Newport-I is more prevalent among humans in Europe than in North America, whereas Newport-II is preferentially associated with animals. Two STs of Newport-II encompassed all MDR-AmpC isolates, suggesting recent global spread after the acquisition of the bla CMY-2 gene. In contrast, most Newport-III isolates were from humans in North America and were pansusceptible to antibiotics. Newport was intermediate in population structure to the other serovars, which varied from a single monophyletic lineage in S. Enteritidis or S. Typhimurium to four discrete lineages within S. Paratyphi B. Both mutation and homologous recombination are responsible for diversification within each of these lineages, but the relative frequencies differed with the lineage. We conclude that serovars of S. enterica provide a variety of different population structures.


2004 ◽  
Vol 46 (3) ◽  
pp. 169-170 ◽  
Author(s):  
Maria Cristina S. Lourenço ◽  
Eliane Falavina M. dos Reis ◽  
Rogério Valls ◽  
Marise Dutra Asensi ◽  
Ernesto Hofer

We described a case of salmonellosis in a 33-year old HIV-infected patient. The patient presented oral and esophageal candidiasis, intense epigastric and retrosternal pain. During the physical examination he was hypochloraemic, acyanotic, hypohydrated, anicteric and afebrile. Admittance laboratorial tests indicated: red cells 3.6 millions/mm³; hemoglobin, 10.1 g/dL; leukocyte count, 3,000/mm³, with 1% of eosinophils, 14% of non-segmented and 53% of segmented neutrophils and 31% of lymphocytes. The blood culture was positive for Salmonella enterica subsp houtenae serogroup O:16. This is probably the first human report of bacteremia due to Salmonella enterica subsp houtenae in Brazil associated to HIV-infected patient.


2019 ◽  
Vol 09 (01) ◽  
Author(s):  
Kolarov C ◽  
Hemmer CJ ◽  
Geerdes-Fenge H ◽  
Loebermann M ◽  
Reisinger EC
Keyword(s):  

mSphere ◽  
2018 ◽  
Vol 3 (6) ◽  
Author(s):  
Ellen E. Higginson ◽  
Girish Ramachandran ◽  
Tracy H. Hazen ◽  
Dane A. Kania ◽  
David A. Rasko ◽  
...  

ABSTRACT Enteric fever is caused by three Salmonella enterica serovars: Typhi, Paratyphi A, and Paratyphi B sensu stricto. Although vaccines against two of these serovars are licensed (Typhi) or in clinical development (Paratyphi A), as yet there are no candidates for S. Paratyphi B. To gain genomic insight into these serovars, we sequenced 38 enteric fever-associated strains from Chile and compared these with reference genomes. Each of the serovars was separated genomically based on the core genome. Genomic comparisons identified loci that were aberrant between serovars Paratyphi B sensu stricto and Paratyphi B Java, which is typically associated with gastroenteritis; however, the majority of these were annotated as hypothetical or phage related and thus were not ideal vaccine candidates. With the genomic information in hand, we engineered a live attenuated S. Paratyphi B sensu stricto vaccine strain, CVD 2005, which was capable of protecting mice from both homologous challenge and heterologous challenge with S. Paratyphi B Java. These findings extend our understanding of S. Paratyphi B and provide a viable vaccine option for inclusion in a trivalent live attenuated enteric fever vaccine formulation. IMPORTANCE We developed a live attenuated Salmonella enterica serovar Paratyphi B vaccine that conferred protection in mice against challenge with S. Paratyphi B sensu stricto and S. Paratyphi B Java, which are the causes of enteric fever and gastroenteritis, respectively. Currently, the incidence of invasive S. Paratyphi B sensu stricto infections is low; however, the development of new conjugate vaccines against other enteric fever serovars could lead to the emergence of S. Paratyphi B to fill the niche left by these other pathogens. As such, an effective S. Paratyphi B vaccine would be a useful tool in the armamentarium against Salmonella infections. Comparative genomics confirmed the serovar-specific groupings of these isolates and revealed that there are a limited number of genetic differences between the sensu stricto and Java strains, which are mostly hypothetical and phage-encoded proteins. The observed level of genomic similarity likely explains why we observe some cross-protection.


2020 ◽  
Vol 2 (8) ◽  
pp. 1236-1239
Author(s):  
Parul Singh ◽  
Aishwarya Govindaswamy ◽  
Pramod Garg ◽  
Purva Mathur

2009 ◽  
Vol 95 (3) ◽  
pp. 237-242 ◽  
Author(s):  
L. Schneider ◽  
M. Ehlinger ◽  
C. Stanchina ◽  
M.-C. Giacomelli ◽  
P. Gicquel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document